PMV Pharmaceuticals, Inc. PMVP
Set alert
1.31 USD 0.00 0.00%
At close · Oct 30
1.31 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
Day range unavailable
1.02 52-week range 1.91
- YTD
- +4.80%
- 1 year
- -6.43%
- Open
- —
- Prev close
- 1.31
- Mkt cap
- 98.92M
- Vol
- 0
- Avg vol
- 686.55K
- EPS
- -1.42
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.96
- Beta
- 1.48
- Short ratio
- 5.17
- Inst. own
- 83.89%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 1.61
- 200-d avg
- 1.65
- 1y target
- 5.80
2Y chart
Events in this range
- Nov 7, 2024Earnings: -0.37; estimate -0.35; surprise -5.71%
Signals (119)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 28, 2026 | 5 days ago |
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 13, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 8, 2026 | 3 weeks ago |
| RSI: Overbought | Oct 1, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 30, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 24, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Sep 4, 2026 | 1 month ago |
| SMA: Bullish | Sep 4, 2026 | 1 month ago |
| SMA: Bearish | Sep 3, 2026 | 2 months ago |
| SMA: Bearish | Sep 2, 2026 | 2 months ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 24, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 24, 2026 | 3 months ago |
| SMA: Bullish | Jul 21, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| SMA: Bullish | Jul 14, 2026 | 3 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | Jun 30, 2026 | 4 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 18, 2026 | 4 months ago |
| RSI: Oversold | Jun 9, 2026 | 4 months ago |
| SMA: Bearish | May 13, 2026 | 5 months ago |
| SMA: Bearish | May 7, 2026 | 5 months ago |
| SMA: Bullish | May 6, 2026 | 6 months ago |
| MACD: Sell Signal | May 1, 2026 | 6 months ago |
| SMA: Bearish | Apr 29, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 14, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bullish | Apr 9, 2026 | 6 months ago |
| SMA: Bearish | Apr 6, 2026 | 7 months ago |
| SMA: Bearish | Apr 6, 2026 | 7 months ago |
| SMA: Bullish | Apr 1, 2026 | 7 months ago |
| SMA: Bullish | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Mar 27, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 17, 2026 | 7 months ago |
| SMA: Bullish | Feb 26, 2026 | 8 months ago |
| SMA: Bullish | Feb 26, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 25, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 20, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 10, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 2, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 26, 2026 | 9 months ago |
| RSI: Oversold | Jan 20, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 12, 2026 | 9 months ago |
| SMA: Bearish | Jan 8, 2026 | 9 months ago |
| SMA: Bullish | Jan 7, 2026 | 9 months ago |
| SMA: Bearish | Jan 2, 2026 | 10 months ago |
| SMA: Bullish | Dec 31, 2025 | 10 months ago |
| SMA: Bearish | Dec 23, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 19, 2025 | 10 months ago |
| SMA: Bearish | Dec 12, 2025 | 10 months ago |
| SMA: Bearish | Dec 5, 2025 | 11 months ago |
| SMA: Bullish | Dec 3, 2025 | 11 months ago |
| SMA: Bearish | Dec 2, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 20, 2025 | 11 months ago |
| SMA: Bearish | Nov 19, 2025 | 11 months ago |
| SMA: Bullish | Nov 17, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 17, 2025 | 11 months ago |
| SMA: Bearish | Nov 13, 2025 | 11 months ago |
| SMA: Bullish | Nov 12, 2025 | 11 months ago |
| SMA: Bearish | Oct 30, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 30, 2025 | 1 year ago |
| SMA: Bullish | Oct 20, 2025 | 1 year ago |
| SMA: Bearish | Oct 17, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 15, 2025 | 1 year ago |
| SMA: Bullish | Oct 14, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Oct 7, 2025 | 1 year ago |
| SMA: Bullish | Oct 3, 2025 | 1 year ago |
| SMA: Bearish | Sep 30, 2025 | 1 year ago |
| SMA: Bullish | Sep 26, 2025 | 1 year ago |
| SMA: Bearish | Sep 25, 2025 | 1 year ago |
| SMA: Bullish | Sep 24, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 24, 2025 | 1 year ago |
| SMA: Bullish | Sep 19, 2025 | 1 year ago |
| SMA: Bearish | Sep 10, 2025 | 1 year ago |
| SMA: Bearish | Sep 10, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 20, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 19, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 7, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 6, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 1, 2025 | 1 year ago |
| RSI: Overbought | Jul 28, 2025 | 1 year ago |
| RSI: Overbought | Jul 24, 2025 | 1 year ago |
| RSI: Overbought | Jul 14, 2025 | 1 year ago |
| RSI: Overbought | Jul 8, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 3, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 27, 2025 | 1 year ago |
| RSI: Overbought | Jun 10, 2025 | 1 year ago |
| SMA: Bullish | Jun 6, 2025 | 1 year ago |
| MACD: Buy Signal | May 20, 2025 | 1 year ago |
| RSI: Oversold | May 15, 2025 | 1 year ago |
| MACD: Sell Signal | May 6, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 15, 2025 | 1 year ago |
| RSI: Oversold | Mar 27, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 26, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 19, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 3, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 27, 2025 | 1 year ago |
| RSI: Oversold | Jan 22, 2025 | 1 year ago |
| RSI: Oversold | Jan 14, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 13, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 2, 2025 | 1 year ago |
Key statistics
- Market cap
- 78.14M
- Enterprise value
- -91.95M
- Trailing P/E
- 0.00
- Forward P/E
- -0.96
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.39
- EPS (TTM)
- -1.00
- Beta
- 1.48
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -39.68M
- Total cash
- 182.84M
- Total debt
- 13.27M
- Return on equity
- -23.63%
- Shares outstanding
- 51.75M
- Short % of float
- 2.01%
- 50-day average
- 1.61
- 200-day average
- 1.65
Analyst view
Consensus: none
Price target (mean) 5.80 +342.7% upside
Now 1.31
- Target (low)
- 5.00
- Target (mean)
- 5.80
- Target (high)
- 7.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 8, 2024
Expected Aug 8, 2024. Consensus EPS estimate -0.3825.
Financials — quick view
PMVP Revenue — quarterly 0
PMVP Net income — quarterly -18.09M
PMVP EPS — quarterly -0.34
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | -0.35 | -0.37 | -0.02 | -5.71% |
| Aug 8, 2024 | Jun 1, 2024 | -0.34 | -0.02 | +0.32 | +94.12% |
| Aug 8, 2024 | Jun 1, 2024 | -0.34 | — | — | — |
| May 9, 2024 | Mar 1, 2024 | -0.35 | -0.30 | +0.05 | +14.29% |
| May 9, 2024 | Mar 1, 2024 | -0.35 | — | — | — |
| Feb 29, 2024 | Dec 1, 2023 | -0.39 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 20, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| May 30, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| May 14, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| May 13, 2024 | Craig-Hallum | init | — | Buy |
| Apr 12, 2024 | Jefferies | init | — | Buy |
| Mar 7, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
About PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- pmvpharma.com
News
- PMV Pharma Raises $50.8 Million to Fuel Cancer Drug Push
- Why Pyxis Tankers Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
- PMV Pharma Q2 EPS $(0.34) Beats $(0.39) Estimate
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- Oppenheimer Maintains Outperform on PMV Pharmaceuticals, Lowers Price Target to $5
- PMV Pharma Q1 EPS $(0.34) Beats $(0.39) Estimate
- PMV Pharmaceuticals Appoints Laurie Stelzer As Board Chair, Effective June 4, Succeeding Rich Heyman
- PMV Pharma Q4 EPS $(0.34) Beats $(0.41) Estimate
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- PMV Pharmaceuticals Announces NEJM Publication Showing Phase 1 Rezatapopt Demonstrates Safety And Antitumor Activity In TP53 Y220C–Mutated Cancers
Your note
Sign in to keep a note on PMVP — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALLAND LEILA | Officer | Sale | Sep 14, 2023 | 45,909 |
| CARULLI MICHAEL | Chief Financial Officer | Sale | Sep 10, 2024 | 88,395 |
| JALOTA DEEPIKA | Officer | Sale | Sep 10, 2024 | 118,283 |
| MACK DAVID HENRY | Chief Executive Officer | Stock Award(Grant) | Jan 17, 2024 | 812,660 |
| ORBIMED ADVISORS, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Sale | Nov 21, 2023 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Orbimed Advisors LLC. | 12.51% | 6,475,291 | 9.78M | Sep 29, 2024 |
| ArrowMark Colorado Holdings LLC | 7.05% | 3,647,291 | 5.51M | Sep 29, 2024 |
| Sio Capital Management, LLC | 6.21% | 3,214,239 | 4.85M | Sep 29, 2024 |
| Euclidean Capital Llc | 5.08% | 2,627,643 | 3.97M | Sep 29, 2024 |
| Alkeon Capital Management LLC | 4.53% | 2,343,731 | 3.54M | Sep 29, 2024 |
| Vanguard Group Inc | 4.41% | 2,280,803 | 3.44M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.95% | 1,524,487 | 2.30M | Sep 29, 2024 |
| Meridian Small Cap Growth Fund | 2.43% | 1,255,473 | 1.90M | Sep 29, 2024 |
| ACAP Strategic Fund | 2.22% | 1,147,095 | 1.73M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.04% | 540,351 | 815.93K | Sep 29, 2024 |
| Advantage Advisers Xanthus Fund, LLC | 0.64% | 329,949 | 498.22K | Sep 29, 2024 |
| BlackRock Advantage Small Cap Core Fund | 0.54% | 280,445 | 423.47K | Aug 30, 2024 |